Sheller on Insider Exclusive “Deadly Drugs: Johnson & Johnson’s Risperdal”
Insider Exclusive Television Documentaries
“Deadly Drugs: Johnson and Johnson’s Risperdal” examines the evolution of the drug Risperdal® from treatment of schizophrenia and extreme bipolar mania to off-label use in children and the elderly for behavior issues, sleep problems, and other uses, some which later became approved by the FDA. What is the cautionary tale? How are consumers and patients affected by the marketing of antipsychotic drugs?
View the documentary here.